Impact of Aberrant beta-Catenin Pathway on Cholangiocarcinoma Heterogeneity

卷:12

Review

关键词: REVERSES MULTIDRUG-RESISTANCE;    WNT SIGNALING PATHWAY;    WNT/BETA-CATENIN;    E-CADHERIN;    GENETIC ALTERATIONS;    TUMOR-SUPPRESSOR;    STEM-CELLS;    CHOLANGIOCYTE CILIA;    MOLECULAR TARGETS;    ALPHA-CATENIN;   

DOI  :  10.3390/cells12081141

来源: SCIE

【 摘 要 】

The poor prognosis of most cases of advanced cholangiocarcinoma (CCA) constitutes a severe problem in modern oncology, which is aggravated by the fact that the incidence of this liver cancer is increasing worldwide and is often diagnosed late, when surgical removal is not feasible. The difficulty of dealing with this deadly tumor is augmented by the heterogeneity of CCA subtypes and the complexity of mechanisms involved in enhanced proliferation, apoptosis avoidance, chemoresistance, invasiveness, and metastasis that characterize CCA. Among the regulatory processes implicated in developing these malignant traits, the Wnt/beta-catenin pathway plays a pivotal role. Alteration of beta-catenin expression and subcellular localization has been associated with worse outcomes in some CCA subtypes. This heterogeneity, which also affects cellular and in vivo models commonly used to study CCA biology and anticancer drug development, must be taken into account for CCA investigation to more accurately extrapolate basic laboratory research to the clinical situation. A better understanding of the altered Wnt/beta-catenin pathway in relationship with the heterogeneous forms of CCA is mandatory for developing novel diagnostic tools and therapeutic strategies for patients suffering from this lethal disease.